Oops! Something went wrong while submitting the form
Oops! Something went wrong while submitting the form
.png)
Being an executive of a company requires a lot from you and being an executive of a publicly traded company can be even more difficult. How do you learn the skills needed to successfully impact your team, manage your board and your investors?
“The real leaders in business, in the professional community, in education, in government, and in the home also seem to draw upon a special cutting edge that separates them from the rest of society. The winner’s edge is not in a gifted birth, in a high IQ, or in talent. The winner’s edge is in the attitude.”
Dr. Huizinga has led teams of highly qualified research leaders internationally and has taught them how to find the attitude that allows their team to perform at the highest level. He has lectured and led leadership classes internationally, and at the local level.
In practical terms, he successfully developed or helped in the development of a novel immunosuppressive medication (voclosporin) from bench to bedside, with submission of NDA to the FDA in less than 6 months from Phase 3 database lock. Voclosporin received FDA approval in 2021 and EMA/MHRA/SwissMedic in 2022, and is a 2022 Prix Galien USA Nominee. Aurinia is one of only three companies in Canada to receive FDA NCE drug approval.
In addition to his real-world experience leading in a biotechnology company that successfully attained drug approvals globally , Dr. Huizinga has a PhD (Organizational Leadership) from Regent University. He has published in leadership journals and is the editor of two texts on leadership. In your sessions, you will learn how to find the attitude that transforms your business, transforms your team and transforms your world.
.png)
.png)
.png)
